An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis - 29/08/11
Abstract |
Seborrheic dermatitis is generally treated with topical steroids, antifungals, or both. This pilot study was undertaken to examine the possibility of tacrolimus as a useful therapy for seborrheic dermatitis. In a single-center, open-label study, 18 consecutive patients with seborrheic dermatitis were treated with 0.1% tacrolimus for a total of 28 days or until complete clearance occurred, if sooner. Of the patients, 11 (61%) showed 100% clearance of their seborrheic dermatitis; the remaining 7 patients showed 70% to 99% clearance. The most common side effects were mild local burning and irritation. (J Am Acad Dermatol 2003;49:145-7.)
Le texte complet de cet article est disponible en PDF.Plan
 | Conflict of interest: None identified. |
| Supported by a grant from Fujisawa Healthcare, Inc, Deerfield, Ill. |
 | Reprint requests: Gerald Weinstein, MD, Department of Dermatology, College of Medicine, C340 Medical Sciences I, Irvine, CA 92697-2400. E-mail: gdweinst@uci.edu. |
| 0190-9622/2003/$30.00 + 0 |
Vol 49 - N° 1
P. 145-147 - juillet 2003 Retour au numéro
Article précédent
- Auricular ossificans (ectopic ossification of the auricle)
- P.Craig Stites, Alan S. Boyd, John Zic
- Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris
- Carlos H. Nousari, Robert Brodsky, Grant J. Anhalt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?